title: Advances in our understanding of aerosolized iloprost for pulmonary hypertension.
authors.forename: P
authors.initials: P
authors.lastname: Diot
authors.forename: P
authors.initials: P
authors.lastname: Magro
authors.forename: L
authors.initials: L
authors.lastname: Vecellio
authors.forename: G C
authors.initials: GC
authors.lastname: Smaldone
mesh_terms: D000336:Aerosols; D000818:Animals; D004361:Drug Tolerance; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D016285:Iloprost / Q000493:pharmacokinetics*; D008168:Lung / Q000187:drug effects*; D009330:Nebulizers and Vaporizers; D010477:Perfusion; D011817:Rabbits; D014665:Vasodilator Agents / Q000493:pharmacokinetics*
chemical_list: D000336:Aerosols; D014665:Vasodilator Agents; D011464:Epoprostenol; D016285:Iloprost